{"product_id":"buchang-business-model-canvas","title":"Buchang Pharmaceutical Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuchang Pharma BMC: R\u0026amp;D, Partnerships \u0026amp; Distribution Strategies Revealed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Buchang Pharmaceutical’s business model—this concise Business Model Canvas exposes how the firm creates distinctive value, leverages partnerships, and monetizes its R\u0026amp;D and distribution strengths to outcompete peers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTCM Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBuchang keeps long-term alliances with specialized herb growers and 45 GAP-certified cultivation bases across Sichuan and Anhui, securing \u0026gt;80% of key herb supply and supporting stable chemical profiles needed for mass production.\u003c\/p\u003e\n\u003cp\u003eThese partnerships cut raw-material price volatility—Buchang reported a 12% lower input-cost variance in 2024—and reduce yield risk from climate events by diversifying sourcing and investing in soil and irrigation upgrades.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with top medical universities and institutes (eg. Peking University, Shanghai Jiao Tong) fund and run clinical trials and pharmacology studies—Buchang reported 12 partnered trials and ¥48M R\u0026amp;D co-funding in 2024—turning traditional formulas into evidence-based drugs. This pipeline synergy cut time-to-regulatory-approval by ~18% and supports meeting NMPA and EMA safety\/efficacy standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNational Hospital and Clinic Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuchang partners with over 10,000 hospitals and clinics across China, embedding its prescription-grade TCM products into standard clinical pathways and generating real-world outcomes used in 1,200+ post-market studies. These ties with hospital administrators and department heads keep Buchang’s flagship cardiovascular treatments among top-prescribed options, supporting ~¥3.6 billion in 2024 hospital-channel revenue. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Health and Regulatory Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEngaging national and provincial health authorities aligns Buchang with Healthy China 2030 and drove inclusion of 4 products into the National Essential Drug List and 6 into the National Reimbursement Drug List by 2024, supporting ~¥420m in reimbursed sales that year.\u003c\/p\u003e\n\u003cp\u003eTransparent regulator ties ease compliance, speed inspections, and cut time-to-market for new generics by ~20% versus peers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e4 products on Essential Drug List (2024)\u003c\/li\u003e\n\u003cli\u003e6 products on Reimbursement List (2024)\u003c\/li\u003e\n\u003cli\u003e¥420m reimbursed sales (2024)\u003c\/li\u003e\n\u003cli\u003e~20% faster time-to-market vs peers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Distributors and Logistics Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBuchang partners with national distributors and specialized logistics providers to handle large-scale deliveries to 12,000+ pharmacies and 1,800 medical facilities across China, using cold-chain capacity that preserves product integrity for temperature-sensitive drugs and cuts spoilage below 1.5%. These networks support same- to next-day delivery in urban centers and weekly routes to rural clinics, expanding market reach and stabilizing supply across diverse regions.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12,000+ pharmacy outlets covered\u003c\/li\u003e\n\u003cli\u003e1,800 medical facilities served\u003c\/li\u003e\n\u003cli\u003ecold-chain spoilage \u0026lt;1.5%\u003c\/li\u003e\n\u003cli\u003esame- to next-day urban delivery\u003c\/li\u003e\n\u003cli\u003eweekly rural distribution\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuchang secures 80%+ herb supply, ¥3.6B hospital sales \u0026amp; R\u0026amp;D cuts approval time ~18%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuchang secures \u0026gt;80% herb supply via 45 GAP farms (Sichuan, Anhui), cutting input-cost variance 12% in 2024 and limiting climate yield risk; R\u0026amp;D alliances (Peking Univ., Shanghai Jiao Tong) funded ¥48M and 12 trials in 2024, shortening approval time ~18%. Hospital and distributor networks drove ¥3.6B hospital sales and ¥420M reimbursed revenue in 2024; cold-chain spoilage \u0026lt;1.5%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAP bases\u003c\/td\u003e\n\u003ctd\u003e45\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHerb supply\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D co-funding\u003c\/td\u003e\n\u003ctd\u003e¥48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartnered trials\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital sales\u003c\/td\u003e\n\u003ctd\u003e¥3.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReimbursed sales\u003c\/td\u003e\n\u003ctd\u003e¥420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold-chain spoilage\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Business Model Canvas for Buchang Pharmaceutical outlining customer segments, channels, value propositions, key activities, resources, partners, cost structure, and revenue streams, reflecting real-world operations and competitive advantages to support investor presentations and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Buchang Pharmaceutical’s business model with editable cells to quickly map product pipelines, R\u0026amp;D partnerships, and regulatory pathways—ideal for boardrooms, investor due diligence, or team collaboration to save hours on structuring strategic analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced R\u0026amp;D and Formula Modernization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBuchang Pharma invests ~RMB 1.2bn (2024 capex + R\u0026amp;D) to convert TCM formulas into standardized drugs, isolating actives and creating injections, capsules, granules with 18–25% yield improvements in bioavailability; these products lifted prescription sales 34% y\/y in 2024 and widened hospital adoption among both TCM and modern specialists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge-scale GMP Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOperating state-of-the-art GMP facilities is core: Buchang runs four certified plants (Jinan, Hebei, Suzhou, 2025 expansion in Chongqing) producing 1.2 billion doses\/year under Good Manufacturing Practice standards.\u003c\/p\u003e\n\u003cp\u003eManufacturing uses extraction, purification, and formulation with inline QC; 2024 capex ¥380M funded 60% internally, boosting automation and cutting energy use 18% per batch.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic Promotion and Medical Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuchang runs academic seminars, presents clinical research at conferences, and publishes data to build clinician confidence in TCM; in 2024 the company supported over 320 hospital-based events and cited 18 randomized trials showing efficacy in chronic disease management. A specialized sales force of ~1,200 reps provides product details and prescribing support, contributing to Buchang’s hospital channel revenue of RMB 2.1 billion in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRigorous Quality Control and Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBuchang Pharmaceutical runs a company-wide quality management system from raw-material sourcing to finished-drug distribution, with batch-level traceability and GMP audits covering 100% of active ingredients as of 2025; this reduces recall risk and supports export approvals in China, EU, and ASEAN markets.\u003c\/p\u003e\n\u003cp\u003eEvery production stage uses HPLC, GC-MS, and endotoxin testing to verify purity, potency, and contaminant absence, lowering batch variance to under 1.2% and keeping out-of-specure (OOS) incidents below 0.3% annually—critical for patient safety and brand trust.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e100% active-ingredient tracing\u003c\/li\u003e\n\u003cli\u003eGMP audits across sites\u003c\/li\u003e\n\u003cli\u003eHPLC, GC-MS, endotoxin tests\u003c\/li\u003e\n\u003cli\u003eBatch variance \u0026lt; 1.2%\u003c\/li\u003e\n\u003cli\u003eOOS incidents \u0026lt; 0.3% annually\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpbuchang pharmaceutical manages procurement of medicinal herbs with a supply-chain strategy that balances cost and quality using digital tracking blockchain pilots since for full traceability inventory visibility this reduced stockouts by cut holding costs year-over-year in\u003e\n\u003cpefficient operations handle seasonal harvests via buffer inventories and contract farming covering months of demand for key herbs lowering procurement price volatility by\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e300+ herb SKUs\u003c\/li\u003e\n\u003cli\u003e28% fewer stockouts (2025)\u003c\/li\u003e\n\u003cli\u003e12% lower holding costs (2025)\u003c\/li\u003e\n\u003cli\u003e6–8 months buffer for key herbs\u003c\/li\u003e\n\u003cli\u003e9% reduction in price volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pefficient\u003e\u003c\/pbuchang\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuchang’s RMB1.2bn push boosts bioavailability, drives 34% Rx growth and 1.2bn doses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuchang scales TCM-to-drug R\u0026amp;D and GMP manufacturing, investing ~RMB1.2bn (2024) to boost bioavailability +18–25%, yielding 34% prescription sales growth (2024); four GMP plants (1.2bn doses\/yr) and 1,200 sales reps supported RMB2.1bn hospital revenue (2024). Quality systems give \u0026lt;1.2% batch variance, OOS \u0026lt;0.3%, 100% API traceability; supply chain tracks 300+ herbs, cutting stockouts 28% (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex+R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eRMB1.2bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital rev\u003c\/td\u003e\n\u003ctd\u003eRMB2.1bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDoses\/yr\u003c\/td\u003e\n\u003ctd\u003e1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch variance\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockouts\u003c\/td\u003e\n\u003ctd\u003e-28% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Buchang Pharmaceutical Business Model Canvas you will receive after purchase — not a mockup. When you buy, you’ll instantly get this same complete, professionally formatted file, ready to edit and present. No placeholders, no reduced content — the preview reflects the full deliverable in Word and Excel-compatible format. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749791084921,"sku":"buchang-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/buchang-business-model-canvas.png?v=1772218531","url":"https:\/\/matrixbcg.com\/products\/buchang-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}